SAWYER JAMES S 4

4 · PRAXAIR INC · Filed Feb 28, 2013

Form 4

Period: 2013-02-26

Executive V.P. and CFO

Transactions

Award
Stock Option (right to buy)
2013-02-26+43,720→ 43,720 total
Exercise: $110.58From: 2014-02-26Exp: 2023-02-26→ Common Stock (43,720 underlying)

Holdings

Common Stock
50,732
Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (37,447 underlying)
37,447
Stock Option (right to buy)
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (27,067 underlying)
27,067
Common Stock
(indirect: By 401(k))
12,703.467
Stock Option (right to buy)
Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (35,814 underlying)
35,814
Stock Option (right to buy)
Exercise: $97.84From: 2012-02-22Exp: 2021-02-22→ Common Stock (56,070 underlying)
56,070
Stock Option (right to buy)
Exercise: $109.68From: 2013-02-28Exp: 2022-02-28→ Common Stock (53,755 underlying)
53,755
Deferred Stock
Exercise: $0.00→ Common Stock (5,115.277 underlying)
5,115.277

Footnotes (8)

[F1]Includes shares of unvested restricted stock.
[F2]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
[F3]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
[F4]This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
[F5]This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
[F6]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
[F7]Conversion to Praxair Common Stock is on a 1-for-1 basis.
[F8]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.

Documents

1 file